Pancreatic Cancer Research

ResearcherUniversity College London Hospitals NHS Foundation TrustActive in the last 2 years

Daniel Hochhauser

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5522-9281; OpenAlex author ID A5085123244. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 6

  1. Impact of Long-Term Chemotherapy on Outcomes in Pancreatic Ductal Adenocarcinoma: A Real-World UK Multi-Centre Study. Co-author DOI 10.3390/cancers17111896↗
  2. Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic C… Co-author DOI 10.1200/jco.21.01604↗
  3. Geographic and Ethnic Heterogeneity of Germline BRCA1 or BRCA2 Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the… Co-author DOI 10.1200/jco.19.01890↗
  4. Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. Co-author DOI 10.1056/nejmoa1903387↗
  5. Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib. Co-author DOI 10.1093/annonc/mdz406↗
  6. The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1). Last author DOI 10.1158/1078-0432.ccr-15-0485↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Talia Golan · 4 shared papers, 2019–2022 · strength 0.36
  2. Dirk Arnold · 4 shared papers, 2019–2022 · strength 0.36
  3. Hedy Lee Kindler · 4 shared papers, 2019–2022 · strength 0.36
  4. Michele Reni · 4 shared papers, 2019–2022 · strength 0.36
  5. Pascal R. Hammel · 4 shared papers, 2019–2022 · strength 0.36
  6. Eric Van Cutsem · 4 shared papers, 2019–2022 · strength 0.36
  7. Teresa Mercade Macarulla · 4 shared papers, 2019–2022 · strength 0.36
  8. Michael J. Hall · 3 shared papers, 2019–2022 · strength 0.29
  9. Joon Oh Park · 3 shared papers, 2019–2022 · strength 0.29
  10. Eileen Mary O'Reilly · 3 shared papers, 2019–2022 · strength 0.27
  11. Do‐Youn Oh · 3 shared papers, 2019–2022 · strength 0.27
  12. Giampaolo Tortora · 3 shared papers, 2019–2022 · strength 0.27
  13. Anke Reinacher‐Schick · 3 shared papers, 2019–2022 · strength 0.27
  14. Hana Algül · 3 shared papers, 2019–2022 · strength 0.27
  15. Umair Mahmood · 1 shared paper, 2025 · strength 0.25
  16. Paul Miller · 1 shared paper, 2025 · strength 0.25
  17. Khurum Hayat Khan · 1 shared paper, 2025 · strength 0.25
  18. Hyun Kyoo Yoo · 1 shared paper, 2019 · strength 0.07
  19. Francesca Vena · 1 shared paper, 2015 · strength 0.06
  20. Thorsten Hagemann · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.